Sponsored Clinical Trial: University of Virginia

CD20 Shaving with Rituxan

Are Standard Dosages Way Too Much?

The original dosing scheme for Rituxan was quite arbitary — but it seemed to do the job. A research team at the University of Virginia is now examining the finer features of how Rituxan works and is asking an important question: when does it make sense to use less of this drug than the dosage standard? In this article we examine the concept of "CD20 shaving" and introduce a research project at UVA that we will be sponsoring and supporting financially. The answers from this research can have an important bearing on the best way to utilize this valuable monoclonal antibody. Details in CD20 Shaving with Rituxan.

Sponsored Clinical Trial: Royal Bournemouth Hospital

Low Hanging Fruit

Improving Routine Immunizations

Sometimes, when luck is running our way and all the stars are in their correct positions in the heavens, everything comes together just so and we have an opportunity to do ourselves a favor as a community. In our new article, Improving Immunizations, we present a clinical trial to test a method that may boost the efficacy of routine immunizations for CLL patients. We are happy to report that Prof. Terry Hamblin is now working on making this trial a reality.

Sponsored Clinical Trial: Mayo Clinic, Rochester, MN

A Patient Sponsored Clinical Trial

Project Alpha Kickoff

It has taken longer than we thought it would, but we are pleased to announce Project Alpha is finally ready to start recruiting patients. It represents a first of its kind collaboration between patients and the research community.  Your hard earned money went into making this "EGCG trial" a reality. You can read all the details of this newly announced clinical trial at Mayo Clinic, Rochester MN, in our new article, Project Alpha Kickoff.

Project Alpha Update

Drum Rolls and Announcements

We Pass Two Milestones

We have some important information to report on our patient-sponsored clinical trial initiative, Project Alpha. First, we have clearance to announce the agents that will be used in the trial. Read Project Alpha Milestones to learn about the agents and the logic for using them. We also finally hear from our favorite governmental agency, the IRS, on our tax-exempt status

Project Alpha Launch

Collaboration with Mayo Clinic, Rochester, MN

Our Clinical Research Partner for Project Alpha

With this December 16, 2024 announcement we officially launch Project Alpha and commence fundraising. Click here to read the Mayo Clinic press release and our announcement.

Project Alpha Proposal

A Patient-Sponsored and Patient-Supported Clinical Trial

CLL Topics Lays Out the Logic and Scientific Background for a Clinical Trial

With this September 22, 2024 announcement we officially launch Project Alpha and commence fundraising. Click here to read the proposal.